Several analysts have recently updated their ratings and price targets for Intuitive Surgical (NASDAQ: ISRG):

  • 8/1/2017 – Intuitive Surgical was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating.
  • 7/26/2017 – Intuitive Surgical had its “hold” rating reaffirmed by analysts at Canaccord Genuity. They now have a $1,000.00 price target on the stock, up previously from $870.00.
  • 7/25/2017 – Intuitive Surgical was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “strong-buy” rating. They now have a $1,067.00 price target on the stock. According to Zacks, “Over the last three months, Intuitive Surgical was trading consistently ahead of the broader industry. While a stellar second-quarter 2017 result was a major market sentiment booster, the company gained significantly on the CE Mark approval for da Vinci X in Europe. The stock has got a further boost on the recent U.S. FDA approval of the same. A positive outlook for the coming quarters also raises our confidence in the stock. Further, incremental spending on product development and higher investments in international markets are prudent moves that are likely to drive long-term growth. The company is also expected to enhance its organizational capabilities and gain prominence in the markets of Europe and Asia. However, the da Vinci Surgical System has a long sale and purchase order cycle which might act against the company. In fact, the stock looks a tad expensive, adding to our concerns.”
  • 7/25/2017 – Intuitive Surgical had its “overweight” rating reaffirmed by analysts at Morgan Stanley. They now have a $1,070.00 price target on the stock, up previously from $950.00.
  • 7/24/2017 – Intuitive Surgical was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating.
  • 7/24/2017 – Intuitive Surgical had its “buy” rating reaffirmed by analysts at Citigroup Inc.. They now have a $1,078.00 price target on the stock, up previously from $917.00.
  • 7/22/2017 – Intuitive Surgical had its “buy” rating reaffirmed by analysts at Stifel Nicolaus. They now have a $1,100.00 price target on the stock, up previously from $850.00.
  • 7/21/2017 – Intuitive Surgical had its “hold” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $1,050.00 price target on the stock. They wrote, “Procedure growth: Guidance for 2017 procedure growth appears to be conservative. ISRG had 17% procedure growth in the 1H and is guiding to 14-15% procedure growth for 2017, implying 11-13% procedure growth in the 2H. The first-half procedure growth came in above expectations, as gynecology (grew in low single digits) and urology (grew in mid-to-high single digits) and China (grew by well over 25%) outpaced expectations. Second-half guidance assumes slower growth in gynecology, urology, and China, one less selling day in 3Q, and lower growth in Japan due to a lack of reimbursement.””
  • 7/21/2017 – Intuitive Surgical had its “hold” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $1,000.00 price target on the stock.
  • 7/21/2017 – Intuitive Surgical had its “overweight” rating reaffirmed by analysts at J P Morgan Chase & Co. They now have a $1,050.00 price target on the stock.
  • 7/21/2017 – Intuitive Surgical had its price target raised by analysts at Barclays PLC from $870.00 to $1,000.00. They now have an “overweight” rating on the stock. They noted that the move was a valuation call. They noted that the move was a valuation call.
  • 7/20/2017 – Intuitive Surgical was downgraded by analysts at Vetr from a “buy” rating to a “hold” rating. They now have a $1,010.56 price target on the stock.
  • 7/18/2017 – Intuitive Surgical had its price target raised by analysts at Royal Bank Of Canada from $800.00 to $950.00. They now have a “sector perform” rating on the stock.
  • 7/12/2017 – Intuitive Surgical had its “outperform” rating reaffirmed by analysts at Wells Fargo & Company. They now have a $1,050.00 price target on the stock, up previously from $1,000.00.
  • 7/11/2017 – Intuitive Surgical had its “hold” rating reaffirmed by analysts at Canaccord Genuity. They now have a $870.00 price target on the stock.
  • 7/5/2017 – Intuitive Surgical had its “outperform” rating reaffirmed by analysts at Leerink Swann.
  • 6/29/2017 – Intuitive Surgical is now covered by analysts at Cantor Fitzgerald. They set a “neutral” rating and a $1,000.00 price target on the stock.
  • 6/23/2017 – Intuitive Surgical was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating.
  • 6/20/2017 – Intuitive Surgical was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Over the last three months, Intuitive Surgical was trading consistently ahead of the broader industry. While a stellar first-quarter 2017 result was a major market sentiment booster, the company gained significantly on the CE Mark approval for da Vinci X in Europe. The stock has got a further boost on the recent U.S. FDA approval of the same. A positive outlook for the coming quarters also raises our confidence in the stock. Further, incremental spending on product development and higher investments in international markets are prudent moves that are likely to drive long-term growth. The company is also expected to enhance its organizational capabilities and gain prominence in the markets of Europe and Asia. However, the da Vinci Surgical System has a long sale and purchase order cycle which might act against the company. In fact, the stock looks a tad expensive, adding to our concerns.”
  • 6/15/2017 – Intuitive Surgical had its “hold” rating reaffirmed by analysts at BTIG Research.
  • 6/13/2017 – Intuitive Surgical was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating.

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) traded down 1.49% on Thursday, hitting $929.38. 254,367 shares of the company’s stock traded hands. Intuitive Surgical, Inc. has a 1-year low of $610.71 and a 1-year high of $974.66. The company has a market cap of $34.53 billion, a price-to-earnings ratio of 44.51 and a beta of 0.39. The firm’s 50-day moving average price is $942.17 and its 200 day moving average price is $831.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $5.79 by $0.16. The company had revenue of $756.20 million during the quarter, compared to analyst estimates of $724.51 million. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The company’s revenue for the quarter was up 12.8% compared to the same quarter last year. During the same period in the previous year, the company earned $5.62 EPS. On average, equities research analysts expect that Intuitive Surgical, Inc. will post $23.86 earnings per share for the current year.

In related news, Director Amal M. Johnson sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 31st. The stock was sold at an average price of $917.27, for a total value of $917,270.00. Following the completion of the transaction, the director now directly owns 3,787 shares in the company, valued at approximately $3,473,701.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Curet Myriam sold 1,202 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $950.20, for a total value of $1,142,140.40. Following the completion of the transaction, the senior vice president now owns 1,428 shares of the company’s stock, valued at $1,356,885.60. The disclosure for this sale can be found here. Insiders have sold a total of 34,065 shares of company stock valued at $31,659,090 over the last 90 days. Corporate insiders own 2.50% of the company’s stock.

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Receive News & Ratings for Intuitive Surgical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc and related companies with MarketBeat.com's FREE daily email newsletter.